🇺🇸 FDA
Patent

US 7232671

Pertussis toxin gene: cloning and expression of protective antigen

granted A61KA61K39/00

Quick answer

US patent 7232671 (Pertussis toxin gene: cloning and expression of protective antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K39/00